Adenovirus-mediated transcriptional targeting of colorectal cancer and effects on treatment-resistant hypoxic cells

Clinical Colorectal Cancer

Volumn 12, Issue 3, 2013, Pages 152-162

  Rajendran, Simon ^a,b   O'Sullivan, Gerald C ^a   O'Hanlon, Deirdre ^b   Tangney, Mark ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b SOUTH INFIRMARY VICTORIA UNIVERSITY HOSPITAL   (Ireland)

Author keywords

CXCR4; Gene delivery; Hypoxia; Luciferase; Tumor

Indexed keywords

ADENOVIRUS VECTOR; CHEMOKINE RECEPTOR CXCR4; FIREFLY LUCIFERASE;

ADULT; AGED; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BREAST TUMOR; CANCER TISSUE; CELL CULTURE; COLORECTAL CANCER; CONTROLLED STUDY; EX VIVO STUDY; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSDUCTION; HISTOLOGY; HUMAN; HUMAN TISSUE; HYPOXIA; HYPOXIC CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; OVARY TUMOR; PHENOTYPE; PROMOTER REGION; REPORTER GENE; TRANSGENE; VIRAL GENE DELIVERY SYSTEM;

CXCR4; GENE DELIVERY; HYPOXIA; LUCIFERASE; TUMOR;

ADENOVIRIDAE; ANOXIA; BREAST NEOPLASMS; COLORECTAL NEOPLASMS; DRUG RESISTANCE, NEOPLASM; FEMALE; FLOW CYTOMETRY; GENES, REPORTER; GENETIC THERAPY; GENETIC VECTORS; HUMANS; OVARIAN NEOPLASMS; RECEPTORS, CXCR4; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 84883143739     PISSN: 15330028     EISSN: 19380674     Source Type: Journal    
DOI: 10.1016/j.clcc.2012.11.005     Document Type: Article

References (54)

1. National Cancer Institute Surveillance Epidemiology and End Results 2005; Cancer Statistics http://seer.cancer.gov/statistics Accessed: December 22, 2012
2. National Cancer Registry Ireland Incidence, Mortality, Treatment and Survival on Cancer in Ireland http://ncri.ie/ncri/index.shtml Accessed: December 22, 2012
3. D.A. Popowich, and A.L. Halverson Medical oncology: multimodality therapy in unresectable colorectal cancer Nat Rev Clin Oncol 6 2009 305 306
4. L. Påhlman Optimal timing of surgery after preoperative chemoradiotherapy for rectal cancer Nat Clin Pract Oncol 6 2009 128 129
5. Z.B. Zhu, J.M. Mathis, and S.K. Makhija Targeting of a conditionally replicative adenovirus agent to human squamous cell carcinomas of the head and neck Int J Oncol 31 2007 1213 1222
6. M.A. Stoff-Khalili, A. Stoff, and A.A. Rivera Preclinical evaluation of transcriptional targeting strategies for carcinoma of the breast in a tissue slice model system Breast Cancer Res 7 2005 R1141 R1152
7. A. Müller, B. Homey, and H. Soto Involvement of chemokine receptors in breast cancer metastasis Nature 410 2001 50 56
8. J.T. Kaifi, E.F. Yekebas, and P. Schurr Tumor-cell homing to lymph nodes and bone marrow and CXCR4 expression in esophageal cancer J Natl Cancer Inst 97 2005 1840 1847
9. K. Yasumoto, K. Koizumi, and A. Kawashima Role of the CXCL12/CXCR4 axis in peritoneal carcinomatosis of gastric cancer Cancer Res 66 2006 2181 2187
10. A.J. Schrader, O. Lechner, and M. Templin CXCR4/CXCL12 expression and signalling in kidney cancer Br J Cancer 86 2002 1250 1256
11. I.S. Zeelenberg, L. Ruuls-Van Stalle, and E. Roos The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases Cancer Res 63 2003 3833 3839
12. A. Ottaiano, R. Franco, and A. Aiello Talamanca Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients Clin Cancer Res 12 2006 2795 2803
13. C.C. Schimanski, S. Schwald, and N. Simiantonaki Effect of chemokine receptors CXCR4 and CCR7 on the metastatic behavior of human colorectal cancer Clin Cancer Res 11 2005 1743 1750
14. J. Kim, H. Takeuchi, and S.T. Lam Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival J Clin Oncol 23 2005 2744 2753
15. M. Lee Hypoxia targeting gene expression for breast cancer gene therapy Adv Drug Deliv Rev 61 2009 842 849
16. G.U. Dachs, and G.M. Tozer Hypoxia modulated gene expression: angiogenesis, metastasis and therapeutic exploitation Eur J Cancer 36 13 spec no 2000 1649 1660
17. M. Nordsmark, S.M. Bentzen, and V. Rudat Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy An international multi-center study Radiother Oncol 77 2005 18 24
18. B.G. Wouters, S.A. Weppler, and M. Koritzinsky Hypoxia as a target for combined modality treatments Eur J Cancer 38 2002 240 257
19. G.U. Dachs, C. Coralli, and S.L. Hart Gene delivery to hypoxic cells in vitro Br J Cancer 83 2000 662 667
20. S. Rajendran, S. Salwa, and X. Gao Ex vivo culture of patient tissue & examination of gene delivery J Vis Exp 2010 pii: 2378
21. S. Rajendran, S. Collins, and J.P. van Pijkeren Targeting of breast metastases using a viral gene vector with tumour-selective transcription Anticancer Res 31 2011 1627 1635
22. J.P. van Pijkeren, D. Morrissey, and I.R. Monk A novel Listeria monocytogenes-based DNA delivery system for cancer gene therapy Hum Gene Ther 21 2010 405 416
23. S. Rajendran, D. O'Hanlon, and D. Morrissey Preclinical evaluation of gene delivery methods for the treatment of loco-regional disease in breast cancer Exp Biol Med (Maywood) 236 2011 423 434
24. S.N. Waddington, J.H. McVey, and D. Bhella Adenovirus serotype 5 hexon mediates liver gene transfer Cell 132 2008 397 409
25. Z.B. Zhu, S.K. Makhija, and B. Lu Transcriptional targeting of adenoviral vector through the CXCR4 tumor-specific promoter Gene Ther 11 2004 645 648
26. S. Ahmad, G. Casey, and P. Sweeney Prostate stem cell antigen DNA vaccination breaks tolerance to self-antigen and inhibits prostate cancer growth Mol Ther 17 2009 1101 1108
27. J. Larkin, D. Soden, and C. Collins Combined electric field and ultrasound therapy as a novel anti-tumour treatment Eur J Cancer 41 2005 1339 1348
28. A. Buhles, S.A. Collins, and J.P. van Pijkeren Anti-metastatic effects of viral and non-viral mediated Nk4 delivery to tumours Genet Vaccines Ther 7 2009 5
29. S. Rajendran, D. O'Hanlon, and D. Morrissey Preclinical evaluation of gene delivery methods for the treatment of loco-regional disease in breast cancer Exp Biol Med (Maywood) 236 2011 423 434
30. B.G. Barnett, B.W. Tillman, and D.T. Curiel Dual targeting of adenoviral vectors at the levels of transduction and transcription enhances the specificity of gene expression in cancer cells Mol Ther 6 2002 377 385
31. M.C. Smith, K.E. Luker, and J.R. Garbow CXCR4 regulates growth of both primary and metastatic breast cancer Cancer Res 64 2004 8604 8612
32. Y. Yuan, G. Hilliard, and T. Ferguson Cobalt inhibits the interaction between hypoxia-inducible factor-alpha and von Hippel-Lindau protein by direct binding to hypoxia-inducible factor-alpha J Biol Chem 278 2003 15911 15916
33. P.J. Ratcliffe, J.F. O'Rourke, and P.H. Maxwell Oxygen sensing, hypoxia-inducible factor-1 and the regulation of mammalian gene expression J Exp Biol 201 1998 1153 1162
34. R.H. Wenger, I. Kvietikova, and A. Rolfs Hypoxia-inducible factor-1 alpha is regulated at the post-mRNA level Kidney Int 51 1997 560 563
35. H.J. Kim, S.J. Yang, and Y.S. Kim Cobalt chloride-induced apoptosis and extracellular signal-regulated protein kinase activation in human cervical cancer HeLa cells J Biochem Mol Biol 36 2003 468 474
36. S.J. Yang, J. Pyen, and I. Lee Cobalt chloride-induced apoptosis and extracellular signal-regulated protein kinase 1/2 activation in rat C6 glioma cells J Biochem Mol Biol 37 2004 480 486
37. D.M. Brizel, G.L. Rosner, and L.R. Prosnitz Patterns and variability of tumor oxygenation in human soft tissue sarcomas, cervical carcinomas, and lymph node metastases Int J Radiat Oncol Biol Phys 32 1995 1121 1125
38. S.A. Hill, L.E. Sampson, and D.J. Chaplin Anti-vascular approaches to solid tumour therapy: evaluation of vinblastine and flavone acetic acid Int J Cancer 63 1995 119 123
39. S.A. Collins, D. Morrissey, and S. Rajendran Comparison of DNA delivery and expression using frequently used delivery methods C. Kang, Gene Therapy - Developments and Future Perspectives 2011 InTech Croatia 247 264
40. B. Kealy, A. Liew, and J.M. McMahon Comparison of viral and nonviral vectors for gene transfer to human endothelial progenitor cells Tissue Eng Part C Methods 15 2009 223 231
41. S.A. Collins, B.A. Guinn, and P.T. Harrison Viral vectors in cancer immunotherapy: which vector for which strategy? Curr Gene Ther 8 2008 66 78
42. B.A. Teicher, and S.P. Fricker CXCL12 (SDF-1)/CXCR4 pathway in cancer Clin Cancer Res 16 2010 2927 2931
43. C. Murdoch CXCR4: chemokine receptor extraordinaire Immunol Rev 177 2000 175 184
44. G.L. Clayman, A.K. el-Naggar, and J.A. Roth In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma Cancer Res 55 1995 1 6
45. O. Greco, B. Marples, and M.C. Joiner How to overcome (and exploit) tumor hypoxia for targeted gene therapy J Cell Physiol 197 2003 312 325
46. M.S. Wiesener, H. Turley, and W.E. Allen Induction of endothelial PAS domain protein-1 by hypoxia: characterization and comparison with hypoxia-inducible factor-1alpha Blood 92 1998 2260 2268
47. J.A. Chiorini, F. Kim, and L. Yang Cloning and characterization of adeno-associated virus type 5 J Virol 73 1999 1309 1319
48. K.R. Zinn, T.R. Chaudhuri, and A.A. Szafran Noninvasive bioluminescence imaging in small animals Ilar J 49 2008 103 115
49. M. Murakami, H. Ugai, and M. Wang An adenoviral vector expressing human adenovirus 5 and 3 fiber proteins for targeting heterogeneous cell populations Virology 407 2010 196 205
50. S. Wirtz, P.R. Galle, and M.F. Neurath Efficient gene delivery to the inflamed colon by local administration of recombinant adenoviruses with normal or modified fibre structure Gut 44 1999 800 807
51. B.H. Shen, and T.W. Hermiston Effect of hypoxia on Ad5 infection, transgene expression and replication Gene Ther 12 2005 902 910
52. J.G. Hay The potential impact of hypoxia on the success of oncolytic virotherapy Curr Opin Mol Ther 7 2005 353 358
53. T. Pipiya, H. Sauthoff, and Y.Q. Huang Hypoxia reduces adenoviral replication in cancer cells by downregulation of viral protein expression Gene Ther 12 2005 911 917
54. Z.S. Guo The impact of hypoxia on oncolytic virotherapy Virus Adaptation Treat 3 2011 71 82